-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Windtree Therapeutics Inc /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- Windtree Therapeutics Inc /De/ Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $86K, a 71.8% decline year-over-year.
- Windtree Therapeutics Inc /De/ Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $740K, a 58% decline year-over-year.
- Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2023 was $1.28M, a 58.6% decline from 2022.
- Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2022 was $3.09M, a 57.4% decline from 2021.
- Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2021 was $7.24M, a 27.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)